Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 169

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Peroxisome Proliferator-Activated Receptor γ Ligands Stimulate Endothelial Nitric Oxide Production Through Distinct Peroxisome Proliferator-Activated Receptor γ–Dependent Mechanisms

Polikandriotis, John A., Mazzella, Louis J., Rupnow, Heidi L., Hart, C. Michael · 2005 · Arteriosclerosis, Thrombosis, and Vascular Biology

Abstract

Objective— We recently reported that the peroxisome proliferator-activated receptor γ (PPARγ) ligands 15-deoxy-Δ 12,14 -prostaglandin J 2 (15d-PGJ 2 ) and ciglitazone increased cultured endothelial cell nitric oxide (NO) release without increasing the expression of endothelial nitric oxide synthase (eNOS). The current study was designed to characterize further the molecular mechanisms underlying PPARγ-ligand–stimulated increases in endothelial cell NO production. Methods and Results— Treating human umbilical vein endothelial cells (HUVEC) with PPARγ ligands (10 μmol/L 15d-PGJ 2 , ciglitazone, or rosiglitazone) for 24 hours increased NOS activity and NO release. In selected studies, HUVEC were treated with PPARγ ligands and with the PPARγ antagonist GW9662 (2 μmol/L), which fully inhibited stimulation of a luciferase reporter gene, or with small interfering RNA to PPARγ, which reduced HUVEC PPARγ expression. Treatment with either small interfering RNA to PPARγ or GW9662 inhibited 15d-PGJ 2 -, ciglitazone-, and rosiglitazone-induced increases in endothelial cell NO release. Rosiglitazone and 15d-PGJ 2 , but not ciglitazone, increased heat shock protein 90-eNOS interaction and eNOS ser 1177 phosphorylation. The heat shock protein 90 inhibitor geldanamycin attenuated 15d-PGJ 2 - and rosiglitazone-stimulated NOS activity and NO production. Conclusions— These findings further clarify mechanisms involved in PPARγ-stimulated endothelial cell NO release and emphasize that individual ligands exert their effects through distinct PPARγ-dependent mechanisms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.atv.0000177805.65864.d4

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 169

Metadata

Authors
Polikandriotis, J. A., Mazzella, L. J., Rupnow, H. L., & Hart, C. M.
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Published
2005-09
Volume
25
Issue
9
Pages
1810-1816
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
OpenAlex
W2119617266
Cited by
169
References
4
FWCI
5.42
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Peroxisome Proliferator-Activated Receptor γ Ligands Stimulate Endothelial Nitric Oxide Production Through Distinct Peroxisome Proliferator-Activated Receptor γ–Dependent Mechanisms. https://app.cochat.ai/papers/10.1161/01.atv.0000177805.65864.d4
The paper
Polikandriotis, J. A., Mazzella, L. J., Rupnow, H. L., & Hart, C. M. (2005). Peroxisome Proliferator-Activated Receptor γ Ligands Stimulate Endothelial Nitric Oxide Production Through Distinct Peroxisome Proliferator-Activated Receptor γ–Dependent Mechanisms. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/01.atv.0000177805.65864.d4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.